| Brand Name | REVANESSE VERSA+ (WITH LIDOCAINE) 1.2ML |
| Common Device Name | REVANESSE VERSA+ (WITH LIDOCAINE) 1.2ML |
| Manufacturer (Section D) |
| PROLLENIUM MEDICAL TECHNOLOGIES INC. |
| 138 industrial parkway north |
| aurora, on L4G 4 C3 |
| CA L4G 4C3 |
|
| Manufacturer (Section G) |
| PROLLENIUM MEDICAL TECHNOLOGIES INC, |
| 138 industrial parkway north, |
|
| aurora, on L4G 4 C3 |
|
CA
L4G 4C3
|
|
| Manufacturer Contact |
|
ario
khoshbin
|
| 138 industrial parkway north, |
| aurora, on L4G 4-C3
|
|
CA
L4G 4C3
|
|
| MDR Report Key | 19924214 |
| Report Number | 3004423487-2024-00017 |
| Device Sequence Number | 2725334 |
| Product Code |
LMH
|
| UDI-Device Identifier | 10669808001038 |
| UDI-Public | 10669808001038 |
| Combination Product (Y/N) | Y |
| Initial Reporter State | CA |
| Initial Reporter Country | US |
| PMA/510(K) Number | P160042 S004 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Serviced by Third Party (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
User Facility |
| Initial Reporter Occupation |
Other Health Care Professional
|
| Remedial Action |
Patient Monitoring |
| Type of Report
| Initial |
| Report Date (Section B) |
08/06/2024 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Health Professional
|
| Device Expiration Date | 04/06/2023 |
| Device Model Number | PN40083 |
| Device Lot Number | 21E014 |
| Was Device Available for Evaluation? |
No
|
| Is the Reporter a Health Professional? |
Yes
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 07/02/2024 |
| Initial Report FDA Received Date | 08/06/2024 |
| Was Device Evaluated by Manufacturer? (Y/N) |
No
|
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
| Outcome Attributed to Adverse Event |
Other;
Other;
|
| Patient Sex | Female |
|
|